0.0650
0.0000
(0.00%)
At close: January 14 at 12:15:51 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
905.8720
660.4030
-437.8320
-1,234.1540
-1,223.3960
Investing Cash Flow
-553.9380
-1,046.8590
-1,208.5160
-140.3640
--
Financing Cash Flow
39.1000
42.5000
253.8800
3,084.7980
1,512.3120
End Cash Position
780.5650
276.5710
620.5270
2,012.9950
302.7150
Capital Expenditure
-553.9380
-1,046.8590
-1,198.5160
-140.3640
--
Issuance of Capital Stock
--
--
--
2,404.0000
626.0000
Issuance of Debt
--
--
--
--
940.0000
Repayment of Debt
-30.0000
--
--
-1,000.0000
-13.6960
Free Cash Flow
351.9340
-386.4560
-1,636.3480
-1,374.5180
-1,223.3960
12/31/2020 - 3/20/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IZO.CN Izotropic Corporation
0.1550
-6.06%
IDTA IDenta Corp.
0.3600
0.00%
SZLSF StageZero Life Sciences Ltd.
0.0016
0.00%
XGN Exagen Inc.
3.0000
-3.85%
SONA.CN Sona Nanotech Inc.
0.2700
+5.88%
APDN Applied DNA Sciences, Inc.
0.1825
-5.64%
TTOO T2 Biosystems, Inc.
0.2900
-9.38%
STIM Neuronetics, Inc.
2.1600
-7.69%
BIAF bioAffinity Technologies, Inc.
0.7575
+0.37%
VCYT Veracyte, Inc.
41.06
-4.02%